EUS is superior for detection of pancreatic lesions compared with standard imaging in patients with multiple endocrine neoplasia type 1

Gastrointestinal Endoscopy

Volumn 81, Issue 1, 2015, Pages 159-167.e2

  Van Asselt, Sophie J ^a   Brouwers, Adrienne H ^a   Van Dullemen, Hendrik M ^a   Van Der Jagt, Eric J ^a   Bongaerts, Alfons H H ^a   Kema, Ido P ^a   Koopmans, Klaas P ^b   Valk, Gerlof D ^c   Timmers, Henri J ^d   De Herder, Wouter W ^e   Feelders, Richard A ^e   Fockens, Paul ^f   Sluiter, Wim J ^a   De Vries, Elisabeth G E ^a   Links, Thera P ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MARTINI HOSPITAL   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYTRYPTOPHAN; AMYLASE; C REACTIVE PROTEIN; CARBON 11; CHROMOGRANIN A; GADOLINIUM; GASTRIN; GLUCAGON; INDIUM 111; NEUROFIBROMIN; PANCREAS POLYPEPTIDE; TUMOR MARKER; CARBON; RADIOPHARMACEUTICAL AGENT;

ABDOMINAL RADIOGRAPHY; ADULT; AGED; AMYLASE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CROSS-SECTIONAL STUDY; EARLY DIAGNOSIS; ECHOENDOSCOPE; ENDOSCOPIC ECHOGRAPHY; FEMALE; FIRST DEGREE RELATIVE; GASTRIN BLOOD LEVEL; GENE MUTATION; GLUCAGON BLOOD LEVEL; HUMAN; MALE; MCNEMAR TEST; MULTIDETECTOR COMPUTED TOMOGRAPHY; MULTIPLE ENDOCRINE NEOPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PANCREAS SCINTISCANNING; PANCREATIC NEUROENDOCRINE TUMOR; PET-CT SCANNER; PRIORITY JOURNAL; PROSPECTIVE STUDY; REAL TIME ULTRASOUND SCANNER; SCINTILLATION CAMERA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SOMATOSTATIN RECEPTOR SCINTIGRAPHY; SPECT SCANNER; TERTIARY HEALTH CARE; TUMOR VOLUME; UNIVERSITY HOSPITAL; ADOLESCENT; COMPLICATION; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; ECHOGRAPHY; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; NEUROENDOCRINE TUMORS; PANCREAS; PANCREATIC NEOPLASMS; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

5-HYDROXYTRYPTOPHAN; ADOLESCENT; ADULT; AGED; CARBON RADIOISOTOPES; CROSS-SECTIONAL STUDIES; EARLY DETECTION OF CANCER; ENDOSONOGRAPHY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; NEUROENDOCRINE TUMORS; PANCREAS; PANCREATIC NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84922850029     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2014.09.037     Document Type: Article

References (36)

1. J.C. Yao, M.P. Eisner, and C. Leary Population-based study of islet cell carcinoma Ann Surg Oncol 14 2007 3492 3500
2. J. Zhou, L. Enewold, and A. Stojadinovic Incidence rates of exocrine and endocrine pancreatic cancers in the United States Cancer Causes Control 21 2010 853 861
3. C.R. Pieterman, M.R. Vriens, and K.M. Dreijerink Care for patients with multiple endocrine neoplasia type 1: the current evidence base Fam Cancer 10 2011 157 171
4. M.L. Brandi, R.F. Gagel, and A. Angeli Guidelines for diagnosis and therapy of MEN type 1 and type 2 J Clin Endocrinol Metab 86 2001 5658 5671
5. R.V. Thakker, P.J. Newey, and G.V. Walls Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1) J Clin Endocrin Metab 97 2012 2990 3011
6. G.M. Doherty, J.A. Olson, and M.M. Frisella Lethality of multiple endocrine neoplasia type 1 World J Surg 22 1998 581 586
7. P.G. Dean, J.A. van Heerden, and D.R. Farley Are patients with multiple endocrine neoplasia type I prone to premature death? World J Surg 24 2000 1437 1441
8. P. Goudet, A. Murat, and C. Binquet Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'Etude des Tumeurs Endocrines) cohort study among 758 patients World J Surg 34 2010 249 255
9. T. Rösch, C.J. Lightdale, and J.F. Botet Localization of pancreatic endocrine tumors by endoscopic ultrasonography N Engl J Med 326 1992 1721 1726
10. P. Langer, P.H. Kann, and V. Fendrich Prospective evaluation of imaging procedures for the detection of pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1 World J Surg 28 2004 1317 1322
11. P.H. Kann, E. Balakina, and D. Ivan Natural course of small, asymptomatic neuroendocrine pancreatic tumours in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study Endocr Relat Cancer 13 2006 1195 1202
12. P. Hellman, Hennings, and G. Akerström Endoscopic ultrasonography for evaluation of pancreatic tumours in multiple endocrine neoplasia type 1 Br J Surg 92 2005 1508 1512
13. L. Thomas-Marques, A. Murat, and B. Delemer Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1 Am J Gastroenterol 101 2006 266 273
14. M.A. Lewis, G.B. Thompson, and W.F. Young Jr. Preoperative assessment of the pancreas in multiple endocrine neoplasia type 1 World J Surg 36 2012 1375 1381
15. A. Sundin, B. Eriksson, and M. Bergström Demonstration of [11C] 5-hydroxy-L-tryptophan uptake and decarboxylation in carcinoid tumors by specific positioning labeling in positron emission tomography Nucl Med Biol 27 2000 33 41
16. 11C-5-hydroxy-tryptophan positron emission tomography J Clin Oncol 26 2008 1489 1495
17. H.R. Balon, S.J. Goldsmith, and B.A. Siegel Procedure guideline for somatostatin receptor scintigraphy with (111)In-pentetreotide J Nucl Med 42 2001 1134 1138
18. 18F-DOPA PET tumour uptake reflects metabolic endocrine tumour activity in patients with a carcinoid tumour Eur J Nucl Med Mol Imaging 38 2011 1854 1861
19. T. Walter, L. Chardon, and X. Chopin-Laly Is the combination of chromogranin A and pancreatic polypeptide serum determinations of interest in the diagnosis and follow-up of gastro-entero-pancreatic neuroendocrine tumours? Eur J Cancer 48 2012 1766 1773
20. W.L. Suarez-Pinzon, and A. Rabinovitch Combination therapy with a dipeptidyl peptidase-4 inhibitor and a proton pump inhibitor induces β-cell neogenesis from adult human pancreatic duct cells implanted in immunodeficient mice Cell Transplant 20 2011 1343 1349
21. L. Landstedt-Hallin, U. Adamson, and P.E. Lins Oral glibenclamide suppresses glucagon secretion during insulin-induced hypoglycemia in patients with type 2 diabetes J Clin Endocrinol Metab 84 1999 3140 3145
22. A.M. Deane, M.J. Chapman, and R.J. Fraser The effect of exogenous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill: a randomised double-blind placebo-controlled cross over study Crit Care 13 2009 R67
23. K.S. Rice, G. Dickson, and M. Lane Elevated serum gastrin levels in Jervell and Lange-Nielsen syndrome: A marker of severe KCNQ1 dysfunction? Heart Rhythm 8 2011 551 554
24. T. Ito, G. Cadiot, and R.T. Jensen Diagnosis of Zollinger-Ellison syndrome: increasingly difficult World J Gastroenterol 18 2012 5495 5503
25. I.M. Modlin, B.I. Gustafsson, and S.F. Moss Chromogranin A-biological function and clinical utility in neuro endocrine tumor disease Ann Surg Oncol 17 2010 2427 2443
26. F. J. Service. Hypoglycemia in adults without diabetes mellitus: diagnostic approach. In: I.B. Hirsch, J.E. Mulder, editors. Up to Date. 2014. Wolters Kluwer Health. Available at: http://www.uptodate.com/contents/hypoglycemia-in-adults-without-diabetes-mellitus-diagnostic-approach? Accessed July1, 2013.
27. J. Iglesias-Garcia, J. Larino-Noia, and I. Abdulkader EUS elastography for the characterization of solid pancreatic masses Gastrointest Endosc 70 2009 1101 1108
28. T. Ishikawa, A. Itoh, and H. Kawashima Usefulness of EUS combined with contrast-enhancement in the differential diagnosis of malignant versus benign and preoperative localization of pancreatic endocrine tumors Gastrointest Endosc 71 2010 951 959
29. C. Barbe, A. Murat, and B. Dupas Magnetic resonance imaging versus endoscopic ultrasonography for the detection of pancreatic tumours in multiple endocrine neoplasia type 1 Dig Liver Dis 44 2012 228 234
30. P.G. Gauger, G.M. Doherty, and J.T. Broome Completion pancreatectomy and duodenectomy for recurrent MEN-1 pancreaticoduodenal endocrine neoplasms Surgery 146 2009 801 808
31. M. Anlauf, R. Schlenger, and A. Perren Microadenomatosis of the endocrine pancreas in patients with and without the multiple endocrine neoplasia type 1 syndrome Am J Surg Pathol 30 2006 560 574
32. M. Voss, P. Hammel, and G. Molas Value of endoscopic ultrasound guided fine needle aspiration biopsy in the diagnosis of solid pancreatic masses Gut 46 2000 244 249
33. M. Atiq, M.S. Bhutani, and M. Bektas EUS-FNA for pancreatic neuroendocrine tumors: a tertiary cancer center experience Dig Dis Sci 57 2012 791 800
34. K. Oberg Circulating biomarkers in gastroenteropancreatic neuroendocrine tumours Endocr Relat Cancer 18 2011 S17 S25
35. M. Peracchi, D. Conte, and C. Gebbia Plasma chromogranin A in patients with sporadic gastro-entero-pancreatic neuroendocrine tumors or multiple endocrine neoplasia type 1 Eur J Endocrinol 148 2003 39 43
36. J.M. de Laat, C.R. Pieterman, and M. Weijmans Low accuracy of tumor markers for diagnosing pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 patients J Clin Endocrinol Metab 98 2013 4143 4151